Wednesday 3 February, 10.30am to 11.15am

The covid pandemic severely affected cancer services in much of the NHS. In some trusts, treatments and operations did not go ahead, causing distress to many patients and their families. In some cases, the risks of carrying out procedures in the midst of a pandemic were felt to outweigh the benefits: in others, hospitals simply did not have the capacity in areas such as ICU to go ahead.  

Across the country, fewer people than would be expected came forward with cancer symptoms making it likely that cancers would be detected at a later stage. There was also a backlog of patients for screening, which was suspended for a time. The NHS is likely to be playing “catch up” with this group of patients for some time to come.

But there was variation in how trusts and integrated care systems managed to cope with cancer services during the first wave of covid and how they were able to restore services during the summer and autumn.  

This webinar, sponsored by Pfizer, will ask what are the lessons for cancer services from the first round of covid? What can be done to help organisations cope in 2021 – when we are likely to still have an issue with covid for at least part of the year? How badly are plans to restore cancer services being affected by the continuing pandemic and, given the delays in diagnoses of many cancers and the hiatus in screening services, how long will it take the NHS’s cancer services to recover from covid?

On the panel will be Ian Vousdenprogramme director, Kent and Medway Cancer Alliance; Lynda Thomas, chief executive, Macmillan Cancer Support; Richard Mitchell, chair East Midlands Cancer Alliance with HSJ bureau chief Ben Clover chairing the discussion.

To watch this live webinar click here to register 

This meeting has been sponsored by Pfizer. The content of this meeting has been solely created, organised, produced and distributed by HSJ.